About DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition... [Read more]
Industry Medical Care Facilities
Sector Healthcare
IPO Date Oct 31, 1995
Employees 70,000
Stock Exchange NYSE
Ticker Symbol DVA
Full Company Profile
Financial Performance
In 2023, DaVita's revenue was $12.14 billion, an increase of 4.57% compared to the previous year's $11.61 billion. Earnings were $691.54 million, an increase of 23.40%.
Financial Statements
Analyst Forecast
According to 3 analysts, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $144.33, which is an increase of 1.53% from the latest price.
Price Target
$144.33
(1.53% upside)
Analyst Consensus: Hold
Stock Forecasts
News
DaVita, Nuwellis Extend Pilot Collaboration for Aquadex
DaVita DVA recently extended the pilot phase of a previously announced supply and collaboration agreement with NuwellisNUWE until Aug 31, 2024.At the conclusion of the pilot phase, DaVita may extend ...
Other symbols: NUWE
15 days ago - Benzinga
DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report
DENVER , May 14, 2024 /PRNewswire/ --Today, DaVita(NYSE: DVA) published its 2023 Community Care Report, underscoring its dedication to corporate social responsibility and commitment to setting a new...
6 weeks ago - PRNewsWire
DaVita Appoints New Chief Information Officer
Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita DENVER , May 13, 2024 /PRNewswire/ -- DaVita,a leading provider of kidney care services, today announce...
6 weeks ago - PRNewsWire
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
DENVER , May 9, 2024 /PRNewswire/ --DaVita Inc.(NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will part...
6 weeks ago - PRNewsWire
DaVita Honors 54 Nephrology Nurses with DAISY Awards
Award celebrates excellence in nursing, underscoring the kidney care provider's commitment to recognizing the indelible impact of clinicians on outstanding patient care DENVER , May 9, 2024 /PRNewswir...
6 weeks ago - PRNewsWire
DaVita gains after upbeat quarterly profit prompts annual forecast raise
DaVita raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell.
7 weeks ago - Reuters
DaVita Inc. 1st Quarter 2024 Results
DENVER , May 2, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March31, 2024. "Through the first quarter, we continued building on the mo...
7 weeks ago - PRNewsWire
Best blue chip healthcare stocks to buy and hold in 2024
The healthcare industry is one of the biggest in the United States and other countries. In the US, the total Medicare expenditure stood at over $927 billion in 2022 and the trend is continuing as the ...
Other symbols: HCAISRG
2 months ago - Invezz
DaVita's Global Operations Powered by 100% Renewable Energy
Kidney care provider enters virtual power purchase agreement in Spain after reaching 100% renewable energy goal in its North American operations DENVER , April 22, 2024 /PRNewswire/ -- By 2025, DaVit...
2 months ago - PRNewsWire
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call
DENVER , April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announcedtoday that it will hold its quarterly conference call to discuss first quarter results onThursday, May 2, 2024, at5:00 p.m....
2 months ago - PRNewsWire
DaVita Announces Dennis Pullin to its Board of Directors
DENVER , April 10, 2024 /PRNewswire/ -- DaVita Inc.today announcedthat its Board of Directors has appointed a new independent director, Dennis Pullin, to join the Board, effective April 10, 2024. "W...
2 months ago - PRNewsWire
The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On
Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month DENVER , March 11, 2024 /PRNewswire/ -- Today,The American D...
3 months ago - PRNewsWire
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024
DENVER , March 8, 2024 /PRNewswire/ -- DaVita Inc.(NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will pa...
3 months ago - PRNewsWire
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador
Expansion would make DaVita the largest dialysis services provider in Latin America DENVER , March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today ann...
4 months ago - PRNewsWire
DaVita Inc. to Participate in the TD Cowen's Health Care Conference 2024
DENVER , Feb. 29, 2024 /PRNewswire/ --DaVita Inc.(NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will pa...
4 months ago - PRNewsWire
DaVita Stock Is Having Its Best Day in Years. Volumes Are Improving After Covid-19.
Dialysis provider DaVita reported fourth-quarter financials above Wall Street's consensus.
4 months ago - Barrons
DaVita gains after co says expects strong 2024 profit
DaVita forecast 2024 profit above Wall Street estimates on Tuesday on anticipated strong demand for its kidney dialysis services, sending its shares up 4.8% after the bell.
4 months ago - Reuters
DaVita Inc. 4th Quarter 2023 Results
DENVER , Feb. 13, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2023. "As we reflect on the past year, our 2023 fin...
4 months ago - PRNewsWire
DaVita Inc. Schedules 4th Quarter 2023 Investor Conference Call
DENVER , Jan. 23, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announcedtoday that it will hold its quarterly conference call to discuss fourth quarter results onTuesday, February 13, 2024, at5:00...
5 months ago - PRNewsWire
DaVita Giving Foundation Invests $1 Million in Western Governors University to Support Nursing Students
Funding to support co-created 'Start Early' program aimed at increasing degree completion rates DENVER , Dec.19, 2023 /PRNewswire/ -- The DaVita Giving Foundation has awarded Western Governors Unive...
6 months ago - PRNewsWire
DaVita's 'Move It With Purpose' Event Achieves Record-Breaking Participation to Support Life-Saving Care
Since 2007, DaVita has raised millions and impacted thousands globally through annual activity-based events DENVER , Nov. 30, 2023 /PRNewswire/ --DaVita, a leading provider of kidney care services, t...
7 months ago - PRNewsWire
Dialysis provider DaVita raises full-year profit outlook, shares rise
Dialysis firm DaVita raises its full-year 2023 adjusted profit per share outlook after beating quarterly revenue estimates, on the back of strong demand, sending shares up nearly 6% in extended tradin...
8 months ago - Reuters
DaVita Inc. 3rd Quarter 2023 Results
DENVER , Nov. 7, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023. "We delivered another strong quarter," said Javier Rod...
8 months ago - PRNewsWire
DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting
Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA , Nov. 2,...
8 months ago - PRNewsWire
DaVita stock price forecast: Ozempic sell-off is an overreaction
DaVita (NYSE: DVA) stock price has come under intense pressure in the past few days. The stock made a big dive on October 9th and crashed to a multi-month low of $71.45.
8 months ago - Invezz
